Lapatinib Plus Capecitabine in Women With HER-2-Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial
Oncologist - United States
doi 10.1634/theoncologist.2009-0181
Full Text
Open PDFAbstract
Available in full text
Date
August 24, 2010
Authors
Publisher
Alphamed Press